Rho-kinase-dependent F-actin rearrangement is involved in the release of endothelial microparticles during IFN-α-induced endothelial cell apoptosis

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 5, 2012, Pages 1152-1160

  Gao, Chengjin ^a   Li, Rongrong ^b   Liu, Yuhao ^a   Ma, Lijie ^a   Wang, Sheng ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Endothelial microparticles; IFN ; Rats; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CD31 ANTIGEN; CD51 ANTIGEN; CD62E PROTEIN; F ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE ANTIGEN; MYELOID DIFFERENTIATION FACTOR 88; RECOMBINANT ALPHA INTERFERON; RHO KINASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CONTROLLED STUDY; DRY WEIGHT; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; LUNG ALVEOLUS WALL; LUNG INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

ACTIN CYTOSKELETON; ACTINS; AMIDES; ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; MALE; PYRIDINES; RATS; RATS, INBRED LEW; RHO-ASSOCIATED KINASES;

EID: 84869881127     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318265d04b     Document Type: Article

References (27)

1. Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hamuro J, Kinoshita S. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction. Cornea. 2011;30 (suppl 1):S54YS59.
2. Mali RS, Ramdas B, Ma P, Shi J, Munugalavadla V, Sims E,Wei L, Vemula S, Nabinger SC, Goodwin CB, et al. Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCRABL. Cancer Cell. 2011;20: 357-369.
3. Munnamalai V, Suter DM. Reactive oxygen species regulate F-actin dynamics in neuronal growth cones and neurite outgrowth. J Neurochem. 2009;108: 644-661.
4. Del Re DP, Miyamoto S, Brown JH. Focal adhesion kinase as a RhoAactivable signaling scaffold mediating Akt activation and cardiomyocyte protection. J Biol Chem. 2008;283: 35622-35629.
5. van der Heijden M, Versteilen AM, Sipkema P, van Nieuw Amerongen GP, Musters RJ, Groeneveld AB. Rho-kinaseYdependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusioninduced endothelial cell apoptosis. Apoptosis. 2008;13: 404-412.
6. Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AC, Nalbone G, Castier Y, Leseche G, Lehoux S, et al. Microparticles from human atherosclerotic plaques promote endothelial ICAM-1Ydependent monocyte adhesion and transendothelial migration. Circ Res. 2011;108: 335-343.
7. Doeuvre L, Plawinski L, Toti F, Anglés-Cano E. Cell-derived microparticles: a new challenge in neuroscience. J Neurochem. 2009;110: 457-468.
8. La Vignera S. Increased expression of endothelial-platelet dysfunctional pathway in patients with arterial erectile dysfunction. Int Angiol. 2011;30: 408-414.
9. Donadee C, Raat NJ, Kanias T, Tejero J, Lee JS, Kelley EE, Zhao X, Liu C, Reynolds H, Azarov I, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation. 2011;124: 465-476.
10. Tsimerman G, Roguin A, Bachar A, Melamed E, Brenner B, Aharon A. Involvement of microparticles in diabetic vascular complications. Thromb Haemost. 2011;106: 310-321.
11. Brunet P, Gondouin B, Duval-Sabatier A, Dou L, Cerini C, Dignat-George F, Jourde-Chiche N, Argiles A, Burtey S. Does uremia cause vascular dysfunction? Kidney Blood Press Res. 2011;34: 284-290.
12. da Silva EF, Fonseca FA, França CN, Ferreira PR, Izar MC, Salomão R, Camargo LM, Tenore SB, Lewi DS. Imbalance between endothelial progenitor cells and microparticles in HIV-infected patients naive for antiretroviral therapy. AIDS. 2011;25: 1595-1601.
13. Burger D, Montezano AC, Nishigaki N, He Y, Carter A, Touyz RM. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/Rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol. 2011;31: 1898-1907.
14. Gelderman MP, Simak J. Flow cytometric analysis of cell membrane microparticles. Methods Mol Biol. 2008;484: 79-93.
15. Morel O, Toti F, Morel N, Freyssinet JM. Microparticles in endothelial cell and vascular homeostasis: are they really noxious?Haematologica. 2009;94: 313-317.
16. Pérez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH. Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects. Haematologica. 2009;94: 387-394.
17. Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, ten Cate H, Leyte A, Terpstra WE, Falanga A. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica. 2009;94: 911-918.
18. Angelot F, Seillès E, Biichlé S, Berda Y, Gaugler B, Plumas J, Chaperot L, Dignat-George F, Tiberghien P, Saas P, Garnache-Ottou F. Endothelial cellderived microparticles induce plasmacytoid dendritic cell maturation: potential implications in inflammatory diseases. Haematologica. 2009;94: 1502-1512.
19. Moriya F, Ogasawara S, Basaki Y, Akiba J, Kojiro S, Fukahori S, Ishizaki H, Nishida N, Matsuoka K, Kojiro M, et al. Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo. Int J Oncol. 2008;33: 647-655.
20. Riley CH, Jensen MK, Brimnes MK, Hasselbalch HC, Bjerrum OW, Straten PT, Svane IM. Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN->. Blood. 2011;118: 2170-2173.
21. Sutherland A, Thomas M, Brandon RA, Brandon RB, Lipman J, Tang B, McLean A, Pascoe R, Price G, Nguyen T, et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit Care. 2011;15:R149.
22. Soleti R, Martínez MC. Microparticles harbouring Sonic Hedgehog: role in angiogenesis regulation. Cell Adh Migr. 2009;3: 293-295.
23. Cinel I, Ark M, Dellinger P, Karabacak T, Tamer L, Cinel L, Michael P, Hussein S, Parrillo JE, Kumar A, et al. Involvement of Rho kinase (ROCK) in sepsis-induced acute lung injury. J Thorac Dis. 2012;4: 30-39.
24. Huang ZH, Wang Y, Yuan XB, He C. RhoA-ROCK-Myosin pathway regulates morphological plasticity of cultured olfactory ensheathing cells. Exp Cell Res. 2011;317: 2823-2834.
25. Chen SC, Liu CC, Huang SY, Chiou SJ. Vascular hyperpermeability in response to inflammatory mustard oil is mediated by Rho kinase in mice systemically exposed to arsenic. Microvasc Res. 2011;82: 182-189.
26. Gao C, Tang J, Li R, Huan J. Specific inhibition of AQP1 water channels in human pulmonary microvascular endothelial cells by small interfering RNAs. J Trauma. 2012;72: 150-161.
27. Matsuoka T, Yashiro M, Kato Y, Shinto O, Kashiwagi S, Hirakawa K. RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility. Clin Exp Metastasis. 2011;28: 627-636.